ASX Announcement 10 September 2026 Clarification of BCAL's position in relation to Genetic Signatures (ASX:GSS) BCAL Diagnostics Limited (ASX: BDX) (BCAL or the Company) refers to the article published in The Australian Financial Review’s Street Talk column on 10 September 2026 headed...